Loading provider…
Loading provider…
Pediatric Hematology & Oncology Physician in New Brunswick, NJ
NPI: 1376553057Primary Employer
Rutgers Health-Rwj Scleroderma Program
rutgershealth.org
HQ Phone
Get MD Peter's Phone Numberphone_androidMobile
Get MD Peter's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.
Authors: Richard Drachtman, Kasey Leger, Stacy Cooper
Publication Date: 2022-09-09
Authors: Richard Drachtman, Bradford Hoppe, Sachin Jhawar
Journal: JAMA Oncol
Authors: Eric Jonasch, Peter Lipsky, Ronnie Fass, Christina Miyake, Lynda Vrooman, Hakan Demirci, Jeffrey Kim, Alejandro Gutierrez, Alice Cheung, Taylor Howard, Santiago Valdes, Lisa Gennarini, Barbara Asselin, Tam Dan Pham, Anita Clayton, Jay Chhablani, Shaine Morris, Amna Qasim, Rodolfo Perini, Benjamin Maughan,
Lead Sponsor: Dana-Farber Cancer Institute
Intervention / Treatment: GENETIC: Leukemia Profiling
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Pharmacological Study, DRUG: Dexamethasone, RADIATION: Radiation Therapy, DRUG: Cyclophosphamide, DRUG: Cytarabine, DRUG: Etoposide, DRUG: Vincristine Sulfate, DRUG: Methotrexate, DRUG: Vincristine, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation, BIOLOGICAL: Blinatumomab, DRUG: Mercaptopurine, DRUG: Therapeutic Hydrocortisone, DRUG: Thioguanine, DRUG: Pegaspargase, DRUG: Leucovorin Calcium, DRUG: Asparaginase, DRUG: Mitoxantrone Hydrochloride, DRUG: Mitoxantrone
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, OTHER: Quality-of-Life Assessment, DRUG: Cyclophosphamide, DRUG: Prednisone, DRUG: Brentuximab Vedotin, DRUG: Etoposide, DRUG: Vincristine Sulfate, DRUG: Methylprednisolone, BIOLOGICAL: Bleomycin Sulfate, DRUG: Doxorubicin Hydrochloride
Journal: J Neuroendocrinol